{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:02:02Z","timestamp":1794070922316,"version":"4.8.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110653","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:18:31Z","timestamp":1597925911000},"page":"110653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Candesartan could ameliorate the COVID-19 cytokine storm"],"prefix":"10.1016","volume":"131","author":[{"given":"Abdel G.","family":"Elkahloun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2020.110653_bib0015","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2174\/0929866524666170728144357","article-title":"Renin-angiotensin system in diabetes","volume":"24","author":"Rein","year":"2017","journal-title":"Protein Pept. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12576-019-00679-4","article-title":"Renin-angiotensin system research: from molecules to the whole body","volume":"69","author":"Takimoto-Ohnishi","year":"2019","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.biopha.2020.110653_bib0025","article-title":"Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients","author":"Liu","year":"2020","journal-title":"medRxiv preprint"},{"issue":"21","key":"10.1016\/j.biopha.2020.110653_bib0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.21037\/atm.2016.11.03","article-title":"Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola","volume":"4","author":"Fedson","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.biopha.2020.110653_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics [published online ahead of print, 2020a","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/157488406776872532","article-title":"Clinical experience with the use of angiotensin receptor blockers in patients with cardiovascular, cerebrovascular and renal diseases","volume":"1","author":"Chrysant","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0045","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2020.110653_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40842-017-0044-1","article-title":"Renin Angiotensin system-modifying therapies are associated with improved pulmonary health","volume":"3","author":"Soto","year":"2017","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"5 Pt 1","key":"10.1016\/j.biopha.2020.110653_bib0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjhyper.2004.11.032","article-title":"Mechanisms for the clinical benefits of angiotensin II receptor blockers","volume":"18","author":"Schmieder","year":"2005","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/15734021113099990002","article-title":"Do RAS inhibitors protect the brain from cerebral ischemic injury?","volume":"9","author":"Hosomi","year":"2013","journal-title":"Curr. Hypertens. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"Pt A","key":"10.1016\/j.biopha.2020.110653_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2017.06.017","article-title":"Beneficial effects of angiotensin II receptor blockers in brain disorders","volume":"125","author":"Saavedra","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0075","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","article-title":"Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death","volume":"15","author":"Rodriguez-Perez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2020.110653_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-015-0167-5","article-title":"An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer\u2019s disease","volume":"8","author":"Elkahloun","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0085","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s12035-019-01800-9","article-title":"Candesartan neuroprotection in rat primary neurons negatively correlates with aging and senescence: a transcriptomic analysis","volume":"57","author":"Elkahloun","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0090","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-020-00219-8","article-title":"Involvement of the nervous system in SARS-CoV-2 infection","volume":"38","author":"Li","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2020.110653_bib0100","article-title":"Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in china [published online ahead of print, 2020 apr 15]","author":"Chen","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2020.110653_bib0105","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China [published online ahead of print, 2020 apr 10]","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2020.110653_bib0110","article-title":"Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features [published online ahead of print, 2020 mar 31]","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.biopha.2020.110653_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100669","article-title":"COVID-19 and intracerebral haemorrhage: causative or coincidental?","volume":"35","author":"Sharifi-Razavi","year":"2020","journal-title":"New Microbes New Infect."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of angiotensin II receptor blockers and ACE (Angiotensin-Converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0130","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2020.110653_bib0135","unstructured":"Gene Set enrichment analysis (GSEA):http:\/\/www.broadinstitute.org\/gsea\/."},{"key":"10.1016\/j.biopha.2020.110653_bib0140","unstructured":"Genome Sequence Archive in BIG Data Center (https:\/\/bigd.big.ac.cn\/) Beijing Institute of Genomics (BIG), Chinese Academy of Sciences."},{"issue":"12","key":"10.1016\/j.biopha.2020.110653_bib0145","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2020.110653_bib0150","unstructured":"Broad Molecular Signatures Database v5.0 (MSigDB) http:\/\/www.broadinstitute.org\/gsea\/."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"issue":"43","key":"10.1016\/j.biopha.2020.110653_bib0160","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopha.2020.110653_bib0165","unstructured":"Ingenuity pathway analysis (IPA), (Ingenuity Systems, Redwood City, CA). (http:\/\/www.ingenuity.com)."},{"key":"10.1016\/j.biopha.2020.110653_bib0170","unstructured":"Gene Ontology (http:\/\/geneontology.org\/)."},{"key":"10.1016\/j.biopha.2020.110653_bib0175","unstructured":"Metascape (https:\/\/metascape.org\/gp\/index.html#\/main\/step1)."},{"key":"10.1016\/j.biopha.2020.110653_bib0180","unstructured":"Jensen Compartments database (https:\/\/compartments.jensenlab.org\/)."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10571-020-00861-y","article-title":"COVID-19, angiotensin receptor blockers, and the brain","volume":"40","author":"Saavedra","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2020.110653_bib0190","article-title":"COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids [published online ahead of print, 2020 Apr 29]","author":"Peters","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3 Suppl","key":"10.1016\/j.biopha.2020.110653_bib0195","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.21873\/invivo.11947","article-title":"Role of Interleukin-6 in lung complications in patients with COVID-19: therapeutic implications","volume":"34","author":"Smetana","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.biopha.2020.110653_bib0200","first-page":"1","article-title":"Biomarkers associated with COVID-19 disease progression [published online ahead of print, 2020 Jun 5]","author":"Ponti","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.biopha.2020.110653_bib0205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fphys.2013.00133","article-title":"Deficiency of Nox2 prevents angiotensin II-induced inward remodeling in cerebral arterioles","volume":"4","author":"Chan","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2020.110653_bib0210","first-page":"1","article-title":"SARS-CoV-2 and myocardial injury: a role for Nox2? [published online ahead of print, 2020 May 12]","author":"Violi","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.biopha.2020.110653_bib0215","article-title":"Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes [published online ahead of print, 2020 Apr 30]","author":"Moreno-Eutimio","year":"2020","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0220","article-title":"Coronavirus COV-19\/SARS-CoV-2 affects women less than men: clinical response to viral infection [published online ahead of print, 2020 Apr 7]","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0225","article-title":"A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly [published online ahead of print, 2020 May 27]","volume":"34","author":"Englmeier","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2020.110653_bib0230","article-title":"Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? [published online ahead of print, 2020 may 8]","author":"Abouhashem","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"18","key":"10.1016\/j.biopha.2020.110653_bib0235","doi-asserted-by":"crossref","first-page":"16374","DOI":"10.1074\/jbc.M110.207738","article-title":"Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression","volume":"286","author":"Piantadosi","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5297","key":"10.1016\/j.biopha.2020.110653_bib0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0245","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110653_bib0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discov."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2004","journal-title":"Mol. Immunol."},{"issue":"5468","key":"10.1016\/j.biopha.2020.110653_bib0260","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"A BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110653_bib0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479-480","author":"Kell","year":"2015","journal-title":"Virology"},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2020.110653_bib0270","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00003246-200201001-00001","article-title":"Toll-like receptor","volume":"30","author":"Lien","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2020.110653_bib0275","article-title":"In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs [published online ahead of print, 2020 May 8]","author":"Choudhury","year":"2020","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4067\/S0716-97602007000200001","article-title":"Toll-like receptors are key participants in innate immune responses","volume":"40","author":"Arancibia","year":"2007","journal-title":"Biol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies [published online ahead of print, 2020 Mar 14]","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2020.110653_bib0290","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.3389\/fmicb.2019.03085","article-title":"Transmissible gastroenteritis virus infection up-regulates FcRn expression via nucleocapsid protein and secretion of TGF-\u03b2 in porcine intestinal epithelial cells","volume":"10","author":"Qian","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biopha.2020.110653_bib0295","article-title":"A role for retinoids in the treatment of COVID-19? [published online ahead of print, 2020 May 27]","author":"Trasino","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0300","article-title":"How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1 [published online ahead of print, 2020 Mar 31]","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0305","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacbts.2020.04.006","article-title":"Precision medicine in COVID-19: IL-1\u03b2 a potential target [published online ahead of print, 2020 Apr 18]","volume":"5","author":"Parisi","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2020.110653_bib0310","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"6487","key":"10.1016\/j.biopha.2020.110653_bib0315","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/370270a0","article-title":"Structure and mechanism of interleukin-1 beta converting enzyme","volume":"370","author":"Wilson","year":"1994","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0320","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1074\/jbc.M113.505636","article-title":"Localization and functionality of the inflammasome in neutrophils","volume":"289","author":"Bakele","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2020.110653_bib0325","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/bi961999z","article-title":"Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties","volume":"36","author":"Wuyts","year":"1997","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0330","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110653_bib0335","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1128\/JVI.02395-10","article-title":"Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species","volume":"85","author":"Smits","year":"2011","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.biopha.2020.110653_bib0340","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1128\/JVI.01033-07","article-title":"The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations","volume":"81","author":"Versteeg","year":"2007","journal-title":"J. Virol."},{"issue":"33","key":"10.1016\/j.biopha.2020.110653_bib0345","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1021\/bi026020q","article-title":"The CXCR3 binding chemokine IP-10\/CXCL10: structure and receptor interactions","volume":"41","author":"Booth","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2020.110653_bib0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system [published online ahead of print, 2020 May 11]","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"12","key":"10.1016\/j.biopha.2020.110653_bib0355","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni735","article-title":"B cells and professional APCs recruit regulatory T cells via CCL4","volume":"2","author":"Bystry","year":"2001","journal-title":"Nat. Immunol."},{"issue":"5482","key":"10.1016\/j.biopha.2020.110653_bib0360","first-page":"1202","article-title":"Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3","volume":"289","author":"McQuibban","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0365","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12250-010-3129-x","article-title":"Cxcl16 interact with SARS-CoV N protein in and out cell","volume":"25","author":"Zhang","year":"2010","journal-title":"Virol. Sin."},{"issue":"Pt 5","key":"10.1016\/j.biopha.2020.110653_bib0375","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1099\/vir.0.028936-0","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease suppressed alpha interferon-induced responses through downregulation of extracellular signal-regulated kinase 1-mediated signalling pathways","volume":"92","author":"Li","year":"2011","journal-title":"J. Gen. Virol."},{"issue":"24","key":"10.1016\/j.biopha.2020.110653_bib0380","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1128\/JVI.01689-12","article-title":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection","volume":"86","author":"Page","year":"2012","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0385","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"23","key":"10.1016\/j.biopha.2020.110653_bib0390","doi-asserted-by":"crossref","first-page":"12047","DOI":"10.1128\/JVI.01057-15","article-title":"Infectious bronchitis coronavirus inhibits STAT1 signaling and requires accessory proteins for resistance to type I interferon activity","volume":"89","author":"Kint","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0395","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0400","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0405","doi-asserted-by":"crossref","first-page":"219","DOI":"10.6026\/97320630016219","article-title":"CoViD-19 immunopathology and immunotherapy","volume":"16","author":"Chiappelli","year":"2020","journal-title":"Bioinformation"},{"key":"10.1016\/j.biopha.2020.110653_bib0410","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure [published online ahead of print, 2020 Apr 17]","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0415","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","article-title":"Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT\/enhancer binding protein","volume":"38","author":"Yan","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2020.110653_bib0420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2017.08.016","article-title":"The phagocyte respiratory burst: historical perspectives and recent advances","volume":"192","author":"Thomas","year":"2017","journal-title":"Immunol. Lett."},{"issue":"70","key":"10.1016\/j.biopha.2020.110653_bib0425","doi-asserted-by":"crossref","first-page":"33416","DOI":"10.18632\/oncotarget.26058","article-title":"Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy","volume":"9","author":"Singer","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0430","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0435","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/vim.2017.0043","article-title":"SOD2 facilitates the antiviral innate immune response by scavenging reactive oxygen species","volume":"30","author":"Wang","year":"2017","journal-title":"Viral Immunol."},{"key":"10.1016\/j.biopha.2020.110653_bib0440","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2018.00182","article-title":"Respiratory disease following viral lung infection alters the murine gut microbiota","volume":"9","author":"Groves","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0445","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/INF.0000000000002343","article-title":"Biomarkers of systemic inflammation in Ugandan infants and children hospitalized with respiratory syncytial virus infection","volume":"38","author":"Sawatzky","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"7","key":"10.1016\/j.biopha.2020.110653_bib0450","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"issue":"7395","key":"10.1016\/j.biopha.2020.110653_bib0455","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","article-title":"IFITM3 restricts the morbidity and mortality associated with influenza","volume":"484","author":"Everitt","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0460","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","article-title":"The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry","volume":"13","author":"Amini-Bavil-Olyaee","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003124","article-title":"IFITM proteins restrict viral membrane hemifusion","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2020.110653_bib0470","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell\u2019s first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu. Rev. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0475","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.micinf.2004.11.004","article-title":"Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells","volume":"7","author":"Leong","year":"2005","journal-title":"Microbes Infect."},{"issue":"12","key":"10.1016\/j.biopha.2020.110653_bib0480","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s13238-014-0104-6","article-title":"Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"issue":"9","key":"10.1016\/j.biopha.2020.110653_bib0485","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/JVI.00338-15","article-title":"Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis","volume":"89","author":"Mielech","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0490","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1074\/jbc.M114.619890","article-title":"p53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling","volume":"290","author":"Yuan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2020.110653_bib0495","doi-asserted-by":"crossref","first-page":"e02140","DOI":"10.1128\/JVI.02140-18","article-title":"Analysis of coronavirus temperature-sensitive mutants reveals an interplay between the macrodomain and papain-like protease impacting replication and pathogenesis","volume":"93","author":"Deng","year":"2019","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0500","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1186\/s12885-016-2873-1","article-title":"The differential role of HTRA1 in HPV-positive and HPV-negative cervical cell line proliferation","volume":"16","author":"Stuqui","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2020.110653_bib0505","first-page":"1","article-title":"A review: does complement or the contact system have a role in protection or pathogenesis of COVID-19? [published online ahead of print, 2020 May 13]","author":"Maglakelidze","year":"2020","journal-title":"Pulm. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0510","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1538-7836.2003.00043.x","article-title":"The discovery of factor V: a tricky clotting factor","volume":"1","author":"Stormorken","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2020.110653_bib0515","first-page":"1","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study [published online ahead of print, 2020 May 4]","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"issue":"192","key":"10.1016\/j.biopha.2020.110653_bib0520","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","article-title":"Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels [published online ahead of print, 2020 May 13]","author":"Demelo-Rodr\u00edguez","year":"2020","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0525","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/ndt\/gfp238","article-title":"Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients","volume":"24","author":"Kasahara","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2020.110653_bib0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105750","article-title":"Telmisartan, an angiotensin II receptor blocker, attenuates Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1\u03b2 in murine macrophages","volume":"75","author":"Choe","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2020.110653_bib0535","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijbiomac.2018.07.149","article-title":"Valsartan prevents glycerol-induced acute kidney injury in male albino rats by downregulating TLR4 and NF-\u03baB expression","volume":"119","author":"Sun","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2020.110653_bib0540","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.taap.2016.06.014","article-title":"TLR4\/MyD88\/NF-\u03baB signaling and PPAR-\u03b3 within the paraventricular nucleus are involved in the effects of telmisartan in hypertension","volume":"305","author":"Li","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0545","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","article-title":"Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury","volume":"36","author":"Wei","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2020.110653_bib0550","first-page":"680","article-title":"Losartan inhibits LPS + ATP-induced IL-1beta secretion from mouse primary macrophages by suppressing NALP3 inflammasome","volume":"69","author":"Wang","year":"2014","journal-title":"Pharmazie"},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0555","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT1 receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0560","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/dmrr.568","article-title":"Inflammation and the etiology of type 2 diabetes","volume":"22","author":"Sj\u00f6holm","year":"2006","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0565","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/01.hjh.0000220417.01397.6a","article-title":"Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation","volume":"24","author":"Schulz","year":"2006","journal-title":"J. Hypertens. Suppl."},{"issue":"13","key":"10.1016\/j.biopha.2020.110653_bib0570","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2174\/138161206776843313","article-title":"Is hypertension an inflammatory process?","volume":"12","author":"Boos","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0575","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2020.110653_bib0580","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exger.2016.09.020","article-title":"Sex differences in angiotensin II responses contribute to a differential regulation of cox-mediated vascular dysfunction during aging","volume":"85","author":"Costa","year":"2016","journal-title":"Exp. Gerontol."},{"issue":"22","key":"10.1016\/j.biopha.2020.110653_bib0585","first-page":"8004","article-title":"Telmisartan inhibits Ang II-induced MMP-9 expression in macrophages in stabilizing atheromatous plaque","volume":"22","author":"Shen","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110653_bib0590","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2008.02.032","article-title":"Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain","volume":"1208","author":"Schmerbach","year":"2008","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.biopha.2020.110653_bib0595","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.numecd.2009.12.016","article-title":"Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production","volume":"21","author":"Shimada","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.biopha.2020.110653_bib0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","article-title":"Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis","volume":"46","author":"Silveira","year":"2013","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0605","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2014.06.011","article-title":"Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation","volume":"236","author":"Clancy","year":"2014","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.biopha.2020.110653_bib0610","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/cvr\/cvy135","article-title":"Functional role of endothelial CXCL16\/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders","volume":"114","author":"Collado","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0615","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.resinv.2012.12.005","article-title":"Preventive effect of irbesartan on bleomycin-induced lung injury in mice","volume":"51","author":"Tanaka","year":"2013","journal-title":"Respir. Investig."},{"issue":"10","key":"10.1016\/j.biopha.2020.110653_bib0620","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.1800619","article-title":"The angiotensin receptor blocker losartan suppresses growth of pulmonary metastases via AT1R-Independent inhibition of CCR2 signaling and monocyte recruitment","volume":"202","author":"Regan","year":"2019","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110653_bib0625","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/ATVBAHA.107.147009","article-title":"CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration","volume":"27","author":"Abu Nabah","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"35","key":"10.1016\/j.biopha.2020.110653_bib0630","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.biopha.2020.110653_bib0635","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.ajpath.2015.06.016","article-title":"Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan","volume":"185","author":"Villapol","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0640","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/ijms17020227","article-title":"Therapeutic effect of losartan, an angiotensin II type 1 receptor antagonist, on CCl\u2084-induced skeletal muscle injury","volume":"17","author":"Hwang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110653_bib0645","article-title":"Rehabilitation management of patients with COVID-19. Lessons learned from the first experiences in China [published online ahead of print, 2020 Apr 24]","author":"Li","year":"2020","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.biopha.2020.110653_bib0650","article-title":"Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis [publiH.-X. onliH.-X. ahead of print, 2020b Apr 1]","author":"Chen","year":"2020","journal-title":"Chin Med. J. (Engl)."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0655","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20120081","article-title":"Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease","volume":"123","author":"Shrikrishna","year":"2012","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0660","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/thx.2003.000893","article-title":"Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist","volume":"59","author":"Otsuka","year":"2004","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0665","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2710.2008.01006.x","article-title":"Effects of angiotensin on the expression of fibrosis-associated cytokines, growth factors, and matrix proteins in human lung fibroblasts","volume":"34","author":"Okada","year":"2009","journal-title":"J. Clin. Pharm. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2020.110653_bib0670","article-title":"Angiotensin II facilitates fibrogenic effect of TGF-\u03b21 through enhancing the downregulation of BAMBI caused by LPS: a new pro-fibrotic mechanism of angiotensin II","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0675","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/08923973.2018.1431924","article-title":"Valsartan attenuates bleomycin-induced pulmonary fibrosis by inhibition of NF-\u03baB expression and regulation of Th1\/Th2 cytokines","volume":"40","author":"Mojiri-Forushani","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0680","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/thx.2010.151555","article-title":"Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis","volume":"66","author":"Plantier","year":"2011","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.biopha.2020.110653_bib0685","doi-asserted-by":"crossref","first-page":"852","DOI":"10.5692\/clinicalneurol.50.852","volume":"50","author":"Hara","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.biopha.2020.110653_bib0690","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan [published online ahead of print, 2020 Apr 12]","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0695","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1139\/y11-105","article-title":"Losartan inhibits STAT1 activation and protects human glomerular mesangial cells from angiotensin II induced premature senescence","volume":"90","author":"Jiao","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0700","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1159\/000487562","article-title":"Angiotensin II regulates Th1 t cell differentiation through angiotensin II type 1 Receptor-PKA-Mediated activation of proteasome","volume":"45","author":"Qin","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.110653_bib0705","article-title":"APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort [published online ahead of print, 2020 May 26]","author":"Kuo","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.biopha.2020.110653_bib0710","article-title":"Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19 [published online ahead of print, 2020 Apr 29]","author":"Zhang","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2020.110653_bib0715","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1515\/hsz-2014-0107","article-title":"Functions of the neuron-specific protein ADAP1 (centaurin-\u03b11) in neuronal differentiation and neurodegenerative diseases, with an overview of structural and biochemical properties of ADAP1","volume":"395","author":"Stricker","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biopha.2020.110653_bib0720","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7072917","article-title":"The differential expression of mitochondrial function-associated proteins and antioxidant enzymes during bovine herpesvirus 1 infection: a potential mechanism for virus infection-induced oxidative mitochondrial dysfunction","volume":"2019","author":"Fu","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2020.110653_bib0725","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","article-title":"Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer\u2019s disease model","volume":"68","author":"Ongali","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2020.110653_bib0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104832","article-title":"Angiotensin receptor blockers and COVID-19","volume":"156","author":"Saavedra","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0735","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0740","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1158\/0008-5472.CAN-19-2257","article-title":"SLC43A3 is a biomarker of sensitivity to the telomeric DNA damage mediator 6-Thio-2\u2019-deoxyguanosine","volume":"80","author":"Mender","year":"2020","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0745","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1161\/ATVBAHA.108.165738","article-title":"Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature","volume":"28","author":"Wallgard","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0750","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","article-title":"Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain","volume":"50","author":"Amphoux","year":"2006","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0755","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.1501802","article-title":"Inducible expression of CXCL1 within the central nervous system amplifies viral-induced demyelination","volume":"196","author":"Marro","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0760","article-title":"Dexamethasone for COVID-19? Not so fast [published online ahead of print, 2020 Jun 4]","volume":"34","author":"Theoharides","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.biopha.2020.110653_bib0765","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2020.05.006","article-title":"Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series [published online ahead of print, 2020 May 25]","volume":"548","author":"Mohtadi","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2020.110653_bib0770","article-title":"Repurposing current therapeutics for treating COVID-19: A vital role of prescription records data mining [published online ahead of print, 2020 May 18]","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0775","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/endo-129-2-1075","article-title":"Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis","volume":"129","author":"Tsutsumi","year":"1991","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0780","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jss.2006.01.026","article-title":"Expression and regulation of AT1 receptor in rat lung microvascular endothelial cell","volume":"134","author":"Zhang","year":"2006","journal-title":"J. Surg. Res."},{"issue":"1-3","key":"10.1016\/j.biopha.2020.110653_bib0785","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.regpep.2009.09.004","article-title":"Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice","volume":"158","author":"Pavel","year":"2009","journal-title":"Regul. Pept."},{"issue":"7","key":"10.1016\/j.biopha.2020.110653_bib0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134175","article-title":"The role of angiotensin II and cyclic AMP in alveolar active sodium transport","volume":"10","author":"Ismael-Badarneh","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0795","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004180000235","article-title":"Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease","volume":"115","author":"Bullock","year":"2001","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0800","doi-asserted-by":"crossref","first-page":"L713","DOI":"10.1152\/ajplung.00103.2001","article-title":"Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II","volume":"282","author":"Papp","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0805","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.abb.2005.06.022","article-title":"LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor","volume":"441","author":"Zhang","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.biopha.2020.110653_bib0810","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1365-2222.2007.02815.x","article-title":"The involvement of type 1a angiotensin II receptors in the regulation of airway inflammation in a murine model of allergic asthma","volume":"37","author":"Ohwada","year":"2007","journal-title":"Clin. Exp. Allergy"},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110653_bib0815","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11010-008-9918-y","article-title":"The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines","volume":"320","author":"Matsuzuka","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0820","first-page":"311","article-title":"The effect of endogenous angiotensin II on alveolar fluid clearance in rats with acute lung injury","volume":"19","author":"Deng","year":"2012","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.biopha.2020.110653_bib0825","doi-asserted-by":"crossref","first-page":"15561","DOI":"10.1038\/srep15561","article-title":"Chronic activation of the renin-angiotensin system induces lung fibrosis","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0830","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1189\/jlb.68.5.700","article-title":"Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP","volume":"68","author":"Raiden","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0835","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.102.037382","article-title":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome","volume":"303","author":"Raiden","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0840","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00210-006-0110-1","article-title":"Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1\/2 and pro-inflammatory signals in the mouse lung","volume":"374","author":"Tanabe","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0845","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jss.2007.03.075","article-title":"Losartan attenuates ventilator-induced lung injury","volume":"145","author":"Yao","year":"2008","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0850","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2008.09.019","article-title":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat","volume":"481","author":"Liu","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0855","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/SHK.0b013e318189017a","article-title":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases","volume":"31","author":"Shen","year":"2009","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0860","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cyto.2009.08.001","article-title":"Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury","volume":"48","author":"Wang","year":"2009","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.biopha.2020.110653_bib0865","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/art.37873","article-title":"Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade","volume":"65","author":"Marut","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.biopha.2020.110653_bib0870","first-page":"15670","article-title":"Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1","volume":"8","author":"Deng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110653_bib0875","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/resp.12781","article-title":"Cardiovascular and antacid treatment and mortality in oxygen-dependent pulmonary fibrosis: a population-based longitudinal study","volume":"21","author":"Ekstr\u00f6m","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.biopha.2020.110653_bib0880","article-title":"Angiotensin II Receptors - Impact for COVID-19 Severity [published online ahead of print, 2020 Jul 9]","author":"Aksoy","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0885","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/HYPERTENSIONAHA.120.15263","article-title":"Evidence that renin-angiotensin system inhibitors should not Be discontinued due to the COVID-19 pandemic","volume":"76","author":"Carey","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2020.110653_bib0890","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.biopha.2020.110653_bib0895","article-title":"Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-COV-2 related lung injury [published online ahead of print, 2020 Jul 8]","author":"Sarzani","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110653_bib0900","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0905","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","article-title":"Treating influenza with statins and other immunomodulatory agents","volume":"99","author":"Fedson","year":"2013","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.110653_bib0910","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/cid\/cit007","article-title":"Potential mechanisms of AT1 receptor blockers on reducing pneumonia-related mortality","volume":"56","author":"Nahmod","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2020.110653_bib0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110165","article-title":"Risk of hospitalization for community acquired pneumonia with renin-angiotensin blockade in elderly patients: a population-based study","volume":"9","author":"Shah","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0920","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/HJH.0000000000000438","article-title":"Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study","volume":"33","author":"Chang","year":"2015","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.biopha.2020.110653_bib0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199981","article-title":"Do outpatient statins and ACEIs\/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study","volume":"13","author":"Kang","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110653_bib0930","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1080\/21645515.2017.1378292","article-title":"Clinician-initiated research on treating the host response to pandemic influenza","volume":"14","author":"Fedson","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.biopha.2020.110653_bib0935","article-title":"Influence of renin-angiotensin system inhibitors on lower-respiratory tract infections in type 2 diabetes: the fremantle diabetes study phase II [published online ahead of print, 2020 Jul 2]","author":"Davis","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2020.110653_bib0940","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2147\/COPD.S104097","article-title":"The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD","volume":"11","author":"Kim","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.biopha.2020.110653_bib0945","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/COPD.S158634","article-title":"Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD","volume":"13","author":"Lai","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.110653_bib0950","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/15412555.2018.1432034","article-title":"Angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a promising medication for chronic obstructive pulmonary disease?","volume":"15","author":"Vasileiadis","year":"2018","journal-title":"COPD"},{"issue":"12","key":"10.1016\/j.biopha.2020.110653_bib0955","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/HJH.0b013e3283314bc7","article-title":"Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes","volume":"27","author":"Larrayoz","year":"2009","journal-title":"J. Hypertens."},{"issue":"6","key":"10.1016\/j.biopha.2020.110653_bib0960","article-title":"Role of the backbenchers of the renin-angiotensin system ACE2 and AT2 Receptors in COVID-19: lessons from SARS","volume":"12","author":"Gumashta","year":"2020","journal-title":"Cureus"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:50:43Z","timestamp":1766083843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220308465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":192,"alternative-id":["S0753332220308465"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110653","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candesartan could ameliorate the COVID-19 cytokine storm","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110653"}}